CAS: 1802706-04-2

(7S)-N-[[5-(Ethylsulfonyl)-2-pyridinyl]methyl]-6,7-dihydro-7-(1-methylethyl)-6-[[trans-4-(trifluoromethyl)cyclohexyl]methyl]-5H-Pyrr olo[3,4-b]pyridine-3-carboxamide

CAS: 1802706-04-2

(7S)-N-[[5-(Ethylsulfonyl)-2-pyridinyl]methyl]-6,7-dihydro-7-(1-methylethyl)-6-[[trans-4-(trifluoromethyl)cyclohexyl]methyl]-5H-Pyrr olo[3,4-b]pyridine-3-carboxamide is a drug candidate for the treatment of lymphocytic leukemia and other cancers. …

• Fórmula: C₂₇H₃₅F₃N₄O₃S
• Pureza: Min. 95%
• Peso molecular: 552.65 g/mol

(7S)-N-[[5-(Ethylsulfonyl)-2-pyridinyl]methyl]-6,7-dihydro-7-(1-methylethyl)-6-[[trans-4-(trifluoromethyl)cyclohexyl]methyl]-5H-Pyrrolo[3,4-b]pyridine-3-carboxamide

CAS: 1802706-04-2

• Fórmula: C₂₇H₃₅F₃N₄O₃S
• Forma y color: Neat
• Peso molecular: 552.652

Vimirogant

CAS: 1802706-04-2

Vimirogant is a RORγ inhibitor (Ki: <100 nM).

• Fórmula: C₂₇H₃₅F₃N₄O₃S
• Pureza: 98%
• Forma y color: Solid
• Peso molecular: 552.65